CodonRX

Curated by Signal

Provider of AI-based probiotic capsules to manage digestive and gut health

Overview

Provider of AI-based probiotic capsules to manage digestive and gut health. It offers NCK2025 a strain of Lactobacillus acidophilus for better gut health and regulating the inflammatory process.

Key facts

Founded: 2021
Headquarters: United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Gateway Biome
Provider of a health screening tool based on functional measures to assess gut microbiome
Life Sciences TechnologyChicago, United States
BaroPace
Developer of smart wearable devices for cardiac health monitoring
Life Sciences TechnologyAshland, United States
OMGenomics
Data visualization software for genomics
Life Sciences TechnologyRedwood City, United States

About CodonRX

What does CodonRX do?

Provider of AI-based probiotic capsules to manage digestive and gut health.

Where is CodonRX headquartered?

CodonRX is headquartered in United States.

When was CodonRX founded?

CodonRX was founded in 2021.

Which sector is CodonRX in?

CodonRX operates in Life Sciences Technology.

Who are CodonRX's competitors?

Companies similar to CodonRX include Gateway Biome, BaroPace, and OMGenomics.